Citation Impact
Citing Papers
Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
2017
First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014
2015
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
Aerosolized Chemotherapy
2008
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Oxidative Stress and Antioxidant Defense
2012 Standout
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
2008 Standout
Titanium dioxide nanoparticles: a review of current toxicological data
2013 Standout
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
2014 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Bioactive peptides and proteins
2003
EGFR Antagonists in Cancer Treatment
2008 Standout
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Changing Concepts of Hormone Receptor–Positive Advanced Breast Cancer Therapy
2012
Targeting hypoxia in cancer therapy
2011 Standout
Cation trapping by cellular acidic compartments: Beyond the concept of lysosomotropic drugs
2011
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications
2003 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Polyanions Protect against the in Vitro Pulmonary Toxicity of Polycationic Paint Components Associated with the Ardystil Syndrome
2001
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
KINETIC ASPECTS OF DRUG DISPOSITION IN THE LUNGS
1999
The molecular biology of head and neck cancer
2010 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Interstitial lung disease guideline
2008
A review of the benefit–risk profile of gefitinib in Asian patients with advanced non‐small‐cell lung cancer
2006
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Organizing pneumonia: the many morphological faces
2001
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
EMT: 2016
2016 Standout
Is Idiopathic Pulmonary Fibrosis an Environmental Disease?
2006
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
2007 Standout
Fleischner Society: Glossary of Terms for Thoracic Imaging
2008 Standout
<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>
2020 Standout
Palbociclib and Letrozole in Advanced Breast Cancer
2016 Standout
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
The PI3K Pathway in Human Disease
2017 Standout
Pulmonary Complications of Novel Antineoplastic Agents for Solid Tumors
2008
Understanding biophysicochemical interactions at the nano–bio interface
2009 Standout
The Bioavailability of Dietary Calcium
2000
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Hypersensitivity pneumonitis: current concepts
2001
An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease
2012 Standout
Clinical Advances in the Diagnosis and Therapy of the Interstitial Lung Diseases
2005
Gefitinib Prevents Bleomycin-induced Lung Fibrosis in Mice
2006
Superoxide Dismutases in the Lung and Human Lung Diseases
2003
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
2003 Standout
Metabolic Activation of the Antitumor Drug 5-(Aziridin-1-yl)-2,4-Dinitrobenzamide (CB1954) by NO Synthases
2008
Factitious asthma. Physiological approach to diagnosis
1982
Bioaerosol Health Effects and Exposure Assessment: Progress and Prospects
2003 Standout
Vocal-Cord Dysfunction Presenting as Asthma
1983 Standout
Pulse proteins: Processing, characterization, functional properties and applications in food and feed
2009 Standout
Desensitization for solid organ and hematopoietic stem cell transplantation
2014
Airborne Nanostructured Particles and Occupational Health
2005
Nanomaterials and nanoparticles: Sources and toxicity
2007 Standout
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
2018 Standout
Nutritional Value and Technological Suitability of Milk from Various Animal Species Used for Dairy Production
2011 Standout
Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants
2003
Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation
2013
Cancer Genome Landscapes
2013 StandoutScience
Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL
2016
Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment
2009 Standout
Bronchiolitis Obliterans Organizing Pneumonia
1994
Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion
2018 Standout
CTLA-4 and PD-1 Pathways
2015 Standout
Works of P. Camus being referenced
Interstitial lung disease induced by exogenous agents: factors governing susceptibility
2001
Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles
2009
Interstitial lung disease associated with drug therapy
2004
Interstitial lung disease in patients with non-small-cell lung cancer: causes, mechanisms and management
2004
Transfusion‐related acute lung injury after intravenous immunoglobulin treatment in a lung transplant recipient
2012
Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma
2012
Reduction of Nilutamide by NO Synthases: Implications for the Adverse Effects of This Nitroaromatic Antiandrogen Drug
2003
Pharmacokinetics of amiodarone in the isolated rat lung.
1990
A novel cause for bronchiolitis obliterans organizing pneumonia: exposure to paint aerosols in textile workshops
1998
Bronchiolitis obliterans organising pneumonia in patients taking acebutolol or amiodarone.
1989
Non-organic acute upper airway obstruction: description and a diagnostic approach.
1980
Drug-induced infiltrative lung disease
2009
Absence d'effet de l'incorporation d'un phosphopeptide du lait sur l'utilisation du calcium et du phosphore chez le jeune porc
1989